FDA Drug Application (201920) for VARENICLINE by TEVA PHARMS USA

Back to FDA Applications sponsored by TEVA PHARMS USA

Application Number201920
Product Number001
FormTABLET; ORAL
Dosage0.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVARENICLINE
Active IngredientVARENICLINE



Back to FDA Applications sponsored by TEVA PHARMS USA